CD19 and precursor B-cell acute lymphoblastic leukemia: The percentages of B220dim CD19+ cells in the BM, spleens, LNs and PB were significantly higher in rmCXCL16-treated Ph+ B-ALL syngeneic transplant mice than in PBS-treated mice (Fig. 7a).